Cargando…
Therapeutic effect of budesonide, montelukast and azithromycin on post-infectious bronchiolitis obliterans in children
Optimal treatment options for post-infectious bronchiolitis obliterans (PIBO) have not yet been established. The present study retrospectively analyzed the effect of budesonide, montelukast and azithromycin on treating PIBO in children <5 years old.. Based on treatment regimen, the cohort was div...
Autores principales: | Chen, Xia, Shu, Jun-Hua, Huang, Yang, Long, Zhen, Zhou, Xiao-Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401899/ https://www.ncbi.nlm.nih.gov/pubmed/32765758 http://dx.doi.org/10.3892/etm.2020.8983 |
Ejemplares similares
-
Follow-up on the therapeutic effects of a budesonide, azithromycin, montelukast, and acetylcysteine (BAMA) regimen in children with post-infectious bronchiolitis obliterans
por: Weng, Tingting, et al.
Publicado: (2021) -
Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
por: Kim, Sei Won, et al.
Publicado: (2016) -
LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats
por: Tu, Zheng-Liang, et al.
Publicado: (2017) -
Long-term effect of azithromycin in bronchiolitis obliterans syndrome
por: Gan, C.Tji-Joong, et al.
Publicado: (2019) -
Post-infectious bronchiolitis obliterans in children: a review of 42 cases
por: Li, Ya-Nan, et al.
Publicado: (2014)